We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Allergy & Immunology

Allergy & Immunology

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Serum Alpha-Linolenic Acid and Long-Term Multiple Sclerosis Activity and Progression: Insights from the BENEFIT Study
Allergy & Immunologylong-term outcomesmultiple sclerosis

Serum Alpha-Linolenic Acid and Long-Term Multiple Sclerosis Activity and Progression: Insights from the BENEFIT Study

By MedXY|Oct 4, 2025

Higher baseline serum alpha-linolenic acid levels predict reduced multiple sclerosis activity, relapses, and disability progression up to 11 years post clinical onset in a large prospective study.

Phase 3 Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis: A Synthesis of Recent Evidence
Allergy & Immunologyclinical trial

Phase 3 Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis: A Synthesis of Recent Evidence

By MedXY|Oct 4, 2025

Inhaled molgramostim, a recombinant human GM-CSF, significantly improves lung gas transfer and quality of life in autoimmune pulmonary alveolar proteinosis, with safety comparable to placebo.

Long-term Ambient Air Pollution Exposure and Asthma Exacerbation Risk in Women: Evidence from the Nurses’ Health Study II
Allergy & Immunologyair pollutionplant-based diet

Long-term Ambient Air Pollution Exposure and Asthma Exacerbation Risk in Women: Evidence from the Nurses’ Health Study II

By MedXY|Oct 4, 2025

Long-term exposure to ambient air pollutants, notably nitrogen dioxide, is linked to increased asthma exacerbations in women, independent of plant-based diet adherence, underscoring the need for stricter air quality standards and targeted r

New insights into food allergy mechanisms—DPEP1, leukotrienes, and the potential of Zileuton
Allergy & Immunologyfood allergy

New insights into food allergy mechanisms—DPEP1, leukotrienes, and the potential of Zileuton

By MedXY|Oct 2, 2025

Two Science papers identify intestinal leukotrienes and DPEP1 gene variants as drivers of oral anaphylaxis in mice, and show that the asthma drug Zileuton largely prevents food‑induced shock in animals, opening new avenues for human trials.

Revolutionizing Ankylosing Spondylitis Assessment: AI-Driven Severity Inspection Model Enhances Diagnostic Precision
AIankylosing spondylitisartificial intelligence

Revolutionizing Ankylosing Spondylitis Assessment: AI-Driven Severity Inspection Model Enhances Diagnostic Precision

By MedXY|Oct 1, 2025

An AI-based model for assessing ankylosing spondylitis severity using spinal X-rays and mSASSS demonstrates high accuracy, offering clinicians a rapid, reliable tool and reducing human resource demands.

Managing Allergies During Pregnancy: Key Tips for Expectant Mothers
Allergy & Immunologyallergieshealth management

Managing Allergies During Pregnancy: Key Tips for Expectant Mothers

By MedXY|Oct 1, 2025

Explore how pregnant women can manage allergies to pollen, dust mites, and pet dander effectively to ensure health and comfort for themselves and their babies.

Emergency Response for Children Allergic to Mosquito and Insect Bites
Allergy & Immunologychildrenmosquito bites

Emergency Response for Children Allergic to Mosquito and Insect Bites

By MedXY|Oct 1, 2025

Children are prone to allergic reactions after mosquito or insect bites. This guide explains how to manage symptoms promptly and effectively to prevent complications.

Understanding and Managing Children’s Allergic Reactions to Mosquito Bites
Allergy & Immunologyallergieschildren

Understanding and Managing Children’s Allergic Reactions to Mosquito Bites

By MedXY|Oct 1, 2025

Explore why children are more prone to allergic reactions from mosquito bites and learn effective prevention and treatment strategies.

Low-Dose Interleukin-2: Unlocking Immune Modulation Across Autoimmune, Neurodegenerative, Metabolic, Transplant, and Inflammatory Diseases
Allergy & Immunologyautoimmunityclinical trials

Low-Dose Interleukin-2: Unlocking Immune Modulation Across Autoimmune, Neurodegenerative, Metabolic, Transplant, and Inflammatory Diseases

By MedXY|Oct 1, 2025

Low-dose IL-2 immunotherapy demonstrates broad, disease-modifying effects by selectively expanding regulatory T cells (Tregs), offering a promising strategy across diverse diseases including autoimmunity, neurodegeneration, metabolic dysfun

Psychedelics Target Neuroimmune Interactions to Limit Fear
Allergy & Immunologyamygdaladepression

Psychedelics Target Neuroimmune Interactions to Limit Fear

By MedXY|Oct 1, 2025

Research reveals how psychedelics modulate immune-to-brain communication to reduce fear, offering new therapeutic avenues for stress-related psychiatric disorders.

Empowering Parents: Acceptance and Commitment Therapy for Children With Asthma and ADHD
Allergy & ImmunologyAcceptance and Commitment TherapyADHD

Empowering Parents: Acceptance and Commitment Therapy for Children With Asthma and ADHD

By MedXY|Oct 1, 2025

A randomized clinical trial demonstrates that an Acceptance and Commitment Therapy-based parenting program reduces health care use, improves asthma control, and alleviates ADHD symptoms in children with both conditions.

Therapeutic Strategies for Disease-Modifying Therapy Management in Pregnant Women With Multiple Sclerosis: Relapse Risk and Clinical Implications
Allergy & ImmunologyDisease-Modifying Therapymultiple sclerosis

Therapeutic Strategies for Disease-Modifying Therapy Management in Pregnant Women With Multiple Sclerosis: Relapse Risk and Clinical Implications

By MedXY|Oct 1, 2025

Managing disease-modifying therapies (DMTs) during pregnancy in women with multiple sclerosis significantly affects relapse risk, with anti-CD20 strategies demonstrating superior protection compared to other approaches.

Peanut Intake in Infants Remains Low Despite Updated Allergy Prevention Guidelines
Allergy & Immunologyfood allergyracial disparities

Peanut Intake in Infants Remains Low Despite Updated Allergy Prevention Guidelines

By MedXY|Oct 1, 2025

Despite recommendations for early allergen introduction, peanut intake among US infants remains low, with significant disparities by age and ethnicity. Tree nut and egg consumption trends also reveal notable demographic and temporal differe

Fine Particulate Matter Exposure Significantly Increases SLE Risk
Allergy & Immunologyair pollutionepidemiology

Fine Particulate Matter Exposure Significantly Increases SLE Risk

By MedXY|Oct 1, 2025

A large Taiwanese cohort study links higher PM2.5 exposure to a more than threefold increased risk of developing systemic lupus erythematosus, underscoring the need for air quality policy interventions.

Long-term Impact of Anifrolumab on Quality of Life in Systemic Lupus Erythematosus: Insights from the TULIP-LTE Trial
Allergy & Immunologyanifrolumabclinical trial

Long-term Impact of Anifrolumab on Quality of Life in Systemic Lupus Erythematosus: Insights from the TULIP-LTE Trial

By MedXY|Oct 1, 2025

A 4-year phase 3 extension study shows that anifrolumab improves patient-reported outcomes and quality of life in systemic lupus erythematosus, with a favorable safety profile.

Prademagene Zamikeracel: A Breakthrough Gene Therapy for Chronic Wounds in Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Allergy & Immunologygene therapyRDEB

Prademagene Zamikeracel: A Breakthrough Gene Therapy for Chronic Wounds in Recessive Dystrophic Epidermolysis Bullosa (RDEB)

By MedXY|Oct 1, 2025

A phase 3 trial demonstrates prademagene zamikeracel significantly accelerates healing and reduces pain in large, chronic RDEB wounds, offering a promising gene therapy with a favorable safety profile.

Comparative Efficacy and Safety of Tolebrutinib in Multiple Sclerosis: Insights from Recent Phase 3 Trials
Allergy & Immunologyclinical trialmultiple sclerosis

Comparative Efficacy and Safety of Tolebrutinib in Multiple Sclerosis: Insights from Recent Phase 3 Trials

By MedXY|Oct 1, 2025

Tolebrutinib reduced disability progression in nonrelapsing secondary progressive MS but did not surpass teriflunomide in reducing relapse rates in relapsing MS. Safety signals include elevated liver enzymes and minor bleeding risks.

Cockroach Immunotherapy Modulates Key T-Cell Responses Regardless of Allergen Extract Abundance
Allergy & Immunologyasthmaimmunotherapy

Cockroach Immunotherapy Modulates Key T-Cell Responses Regardless of Allergen Extract Abundance

By MedXY|Sep 30, 2025

A randomized trial finds that subcutaneous cockroach immunotherapy effectively downregulates dominant T-cell responses in pediatric asthma, independent of allergen abundance in the therapeutic extract.

Digital Self-Management Tools Enhance Asthma Control
Allergy & Immunologyasthmadigital health

Digital Self-Management Tools Enhance Asthma Control

By MedXY|Sep 30, 2025

A randomized trial shows that a smartphone-based asthma self-management program improves symptom control in adults, though its effectiveness is attenuated in African American participants.

Prev
6 / 6
1…456
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities

Browse by specialty

Open language-specific specialty feeds and department pages.

news6629 articlesCardiology1375 articlesClinical Updates1288 articlesOncology1139 articlesDiabetes & Endocrinology842 articlesNeurology820 articlesPublic Health595 articlesGastroenterology572 articles
Hematology-Oncology
487 articles
Pediatrics484 articles
Internal Medicine444 articles